XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.3

Organization and Summary of Significant Accounting Policies (Details) - Schedule of Research and Development Expense - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule of Research and Development Expense [Abstract]
Fair value of 8,000,000 shares Dragon shares transferred based on recent sales of Dragon shares at $0.30 per share	$ 2,400,000
Less: gain recognized as difference between fair value of 8,000,000 shares calculated above and allocated costs of investment in Dragon and included in research and development	(2,233,333)
Research and development expense recorded, net	$ 166,667	$ 63,801

X

- Definition

Less gain recognized as difference between fair value of shares

+ References

No definition available.

+ Details

Name:	dats_LessGainRecognizedAsDifferenceBetweenFairValueOfShares
Namespace Prefix:	dats_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Research and Development Fair Value.

+ References

No definition available.

+ Details

Name:	dats_ResearchandDevelopmenFairValue
Namespace Prefix:	dats_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of other research and development expense.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

+ Details

Name:	us-gaap_OtherResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpenseAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration